All In MedTech

Device Trial Radar · NCT03499821

Clinical Performance of a Phakic Intraocular Lens (IOL)

A Multicenter Clinical Evaluation of the Clinical Performance of a Phakic Intraocular Lens

Last checked: Nov 20, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

41

Actual

Start

Mar 20, 2018

Primary completion

Jul 9, 2019

Study completion Jul 9, 2019

Sponsor

Lead sponsor
Staar Surgical CompanyNot on our public-company list
Sponsor type
Industry
First posted
Apr 17, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the clinical performance of a phakic intraocular lens (IOL) for the improvement of Uncorrected Near Visual Acuity (UCNVA) in subjects who require between +1.00 and +2.50 Reading Add.

Conditions

  • Presbyopia

Interventions

  • EDOF ICLDevice

    The Visian ICL is intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens. It offers an intraocular alternative for the correction of refractive error in those who currently utilize spectacle and/or contact lenses correction.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Eyes With Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 6 Months After ImplantationTime frame: 6 months

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Mediopolis

    Antwerp, Belgium

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.